Provided by Tiger Fintech (Singapore) Pte. Ltd.

FOSUN INTL

4.200
+0.1704.22%
Volume:3.75M
Turnover:15.58M
Market Cap:34.36B
PE:-7.31
High:4.200
Open:3.960
Low:3.960
Close:4.030
Loading ...

Peak Re P&C combined ratio improves to 84% in 2024

Reuters
·
30 Apr

Peak Re sponsors $50 million cat bond covering Japan, China and India

Reuters
·
30 Apr

Fosun Pharma Makes Senior Management Changes

MT Newswires Live
·
30 Apr

Shanghai Fosun Pharmaceutical's Q1 Profit Jumps 25%; Hong Kong Shares Slide 4%

MT Newswires Live
·
30 Apr

Fakeeh Care Signs MoU With Shanghai Fosun Pharmaceutical

Reuters
·
28 Apr

BRIEF-Nanyang Commercial Bank Enters Into Strategic Cooperation Agreement With Fosun International

Reuters
·
24 Apr

Nanyang Commercial Bank Enters Into Strategic Cooperation Agreement With Fosun International

THOMSON REUTERS
·
24 Apr

Fosun International Unit to Boost Stake in Henlius Biotech

MT Newswires Live
·
22 Apr

Exclusive: JP Morgan leading process for potential $3 billion AF Group sale

Reuters
·
22 Apr

BRIEF-Fosun International Announces Transaction In Relation To Acquisition Of Henlius

Reuters
·
21 Apr

Fosun International - Henlink Agreed to Sell 14.9 Mln Unlisted Shares of Henlius to Fosun Pharma Industrial at HKD24.6 per Share

THOMSON REUTERS
·
21 Apr

Discloseable Transaction in Relation to Acquisition of Henlius

THOMSON REUTERS
·
21 Apr

Fosun International - Total Consideration Is HKD367.5 Mln

THOMSON REUTERS
·
21 Apr

Shanghai Fosun Pharmaceutical to Sell 55% Stake in Investment Firm

MT Newswires Live
·
14 Apr

BUZZ-Indian drugmakers fall after Trump signals 'major' pharma tariffs

Reuters
·
09 Apr

Indian pharma stocks decline after Trump again threatens tariffs

Reuters
·
09 Apr

Fosun Pharmaceutical Gets Clinical Trial Approval for Schizophrenia Drug

MT Newswires Live
·
08 Apr

Fosun Pharmaceutical Unit Gets China Nod for Schizophrenia Drug Trial

MT Newswires Live
·
08 Apr

The world's first AI-AGENT in the entertainment industry and fan economy ecosystem community MEET48 has successfully completed its token financing round, with Liang Xinjun, Hash Global, and Hashkey Capital leading the investment.

Blockbeats
·
04 Apr

Pharma stocks climb on US tariff exemption, but uncertainty continues

Reuters
·
03 Apr